NCT07037966 Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI
| NCT ID | NCT07037966 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Investigacion Sanitaria La Fe |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-11-07 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-11-07 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mobile imaging diagnostic devices are extremely valuable for clinical diagnosis both inside and outside healthcare facilities. However, Magnetic Resonance Imaging (MRI)-the gold standard for diagnosing many neurological and musculoskeletal conditions-is not easily portable. Moreover, due to its high cost (in the million-euro range) and limited availability, the average wait time in Europe for an MRI scan is from several weeks to months. The NextMRI project aims to take the technical, industrial, and commercial steps required to deploy portable low-field MRI systems in remote and developing regions, rural areas, sporting events, military or medical camps, and home healthcare settings, improving diagnostic capabilities. The specific goals of the NextMRI project are: 1. Expand current low-field MRI technology to brain imaging. 2. Enhance diagnostic accuracy using machine learning. 3. Improve portability and usability for end users. 4. Reduce production costs for broader affordability. 5. Collect clinical evidence through trials to validate medical performance. 6. Develop a sustainable business model for market commercialization.
Eligibility Criteria
Inclusion Criteria: * Patients with suspected multiple sclerosis Exclusion Criteria: * Any contradictions for high-field MRI
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07037966 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07037966 currently recruiting?
Yes, NCT07037966 is actively recruiting participants. Contact the research team at paula_doria@iislafe.es for enrollment information.
Where is the NCT07037966 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT07037966 clinical trial?
NCT07037966 is sponsored by Instituto de Investigacion Sanitaria La Fe. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.